Periodic Reporting for period 4 - anTBiotic (AnTBiotic – progressing TB drug candidates to clinical proof of concept)

anTBiotic aims to fuel the Tuberculosis (TB) clinical pipeline while also immediately offering new options to clinicians when confronted with drug-resistant (DR)-TB.TB is the second leading cause of death from infectious diseases after COVID. The number of patients has never...